Tinea pedis (Athlete Foot) Global Clinical Trials Review, H1, 2016

$2,500

March - 2016
In Healthcare
By Global Data

1166 Views

GlobalData’s clinical trial report, “Tinea pedis (Athlete Foot) Global Clinical Trials Review, H1, 2016″ provides an overview of Tinea pedis (Athlete Foot) clinical trials scenario. This report provides top line data relating to the clinical trials on Tinea pedis (Athlete Foot). Report includes an overview of trial numbers and their average enrollment in top countries …..

Total Pages: 64

GlobalData's clinical trial report, “Tinea pedis (Athlete Foot) Global Clinical Trials Review, H1, 2016" provides an overview of Tinea pedis (Athlete Foot) clinical trials scenario. This report provides top line data relating to the clinical trials on Tinea pedis (Athlete Foot). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Tinea pedis (Athlete Foot) to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Tinea pedis (Athlete Foot) to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Tinea pedis (Athlete Foot) Therapeutics Clinical Trials 25
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 61
Abbreviations 61
Definitions 61
Research Methodology 62
Secondary Research 62
About GlobalData 63
Contact Us 63
Disclaimer 63
Source 64

List of Tables
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials by Region, 2016* 5
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 12
Proportion of Tinea pedis (Athlete Foot) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Tinea pedis (Athlete Foot) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Tinea pedis (Athlete Foot) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Tinea pedis (Athlete Foot) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Tinea pedis (Athlete Foot) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Tinea pedis (Athlete Foot) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 21
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22
Tinea pedis (Athlete Foot) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 23
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List of Figures
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 12
Proportion of Tinea pedis (Athlete Foot) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 13
Tinea pedis (Athlete Foot) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Tinea pedis (Athlete Foot) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Tinea pedis (Athlete Foot) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 16
Tinea pedis (Athlete Foot) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
Tinea pedis (Athlete Foot) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Tinea pedis (Athlete Foot) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 20
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 22
Tinea pedis (Athlete Foot) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 23
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 24
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Tinea pedis (Athlete Foot) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27
GlobalData Methodology 62

Tinea pedis (Athlete Foot) Global Clinical Trials Review, H1, 2016

Subscribe

Subscribe us for latest industry updates.

New Customer?

Have Questions?

Why MRAS?

Quick Links

Connect with Us:

Address

Business Hours

Payment Methods

Secured with